Peer Review History
Original SubmissionJune 11, 2023 |
---|
PONE-D-23-18094Domestic dogs maintain clinical, nutritional, and hematological health outcomes when fed a commercial plant-based diet for a yearPLOS ONE Dear Dr. Melgarejo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 09 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Juan J Loor Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: AL & TM received research funding from Plant-Based Dog Food Health Study Initiative in Los Angeles, California, WesternU College of Veterinary Medicine Office for Research, the True One Medicine Initiative at WU. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Thank you for providing the following Funding Statement: AL & TM received research funding from Plant-Based Dog Food Health Study Initiative in Los Angeles, California, WesternU College of Veterinary Medicine Office for Research, the True One Medicine Initiative at WU. We note that one or more of the authors is affiliated with the funding organization, indicating the funder may have had some role in the design, data collection, analysis or preparation of your manuscript for publication; in other words, the funder played an indirect role through the participation of the co-authors. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study in the Author Contributions section of the online submission form. Please make any necessary amendments directly within this section of the online submission form. Please also update your Funding Statement to include the following statement: “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If the funding organization did have an additional role, please state and explain that role within your Funding Statement. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. 4. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. Please clarify whether this publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This project aimed to look at the health of dogs fed a K9PBD for 12 months by evaluating overt clinical health, blood work, and nutrient biomarkers. The investigators noted no statistical change over time within the sample population following long term ingestion of a non-animal protein based diet. Secondarily, the authors were notably trying to highlight the lack of change in cardiac biomarkers when fed a pea protein diet to reduce the fears of dietary-induced cardiomyopathy. The reviewer believes that this study does not meet rigorous research standards due to many omissions, including nutrition information each individual subjects' diets before the study and the feeding recommendations during the study. In addition, sweeping comments regarding cardiac health are questionable as true evaluation of cardiac function was not performed; cardiac biomarkers have significant limitations and are not recommended for screening in a general healthy dog population. This study was simple and should be stated as such- maybe a brief communication rather then a publication. The reviewer would not have read this paper after reading the MM; the author should request critical appraisal prior to submission. Introduction: The reviewer notes that in this introduction, the concern over cardiomyopathy in dogs eating non-traditional foods was not addressed as this was in large part an important portion of the study design and discussion. If the audience for this publication is veterinary health professionals, whom are making the recommendations to pet owners regarding diet, it is essential to highlight the "whys" of this project. Line 80- Conclusions should not be in the introduction Study Design: This is a small study population (n=17) and a biased population as people enrolled were all participants in health sciences; if many of these dogs were owned by the veterinary population, stronger bias exists. As the veterinarian evaluating the dogs was not blinded, this should be duly noted. What were the inclusion/exclusion criteria? The client questionnaire should be in supplementary material and noted that it is not validated. No mention of the feeding recommendations is noted- this is essential as the author addresses BCS and body weight. This is an oversight that cannot go overlooked. Discussion: The reviewer notes areas in the discussion which are superfluous and areas that are considerably lacking. Lines 347-353, which in fact states that dogs can maintain health over time on a meat free diet (which was published in 2009). The current study, therefore, does not provide additional information to the reader. Lines 358-359 the author highlights the reduction in BCS- as no feeding recommendations were noted nor compared with previous kcal, protein, fat, carbohydrate consumption this finding is questionable to be a result of a plant based diet. The change simply may have been a reduction in calories ingested at the bare minimum. The diets ingested prior to the study were not mentioned- therefore the reader has no idea how to compare this change. No mention of muscle condition scoring is noted; did the dogs loose/maintain muscle mass? Were their changes in exercise/environment/etc? Since the owners were not blinded, were they also biased in their reporting? Evaluation of biomarkers is very questionable as they have limited clinical screening use in healthy dogs. The reviewer does not agree with the conclusion that the study findings alleviate any of the cardiomyopathy concerns as no true screening (VHS, Echo) was completed prior to diet change or after 1 year on the diet. To interpret the biomarkers, the prevalence of disease in the population needs to be considered as well as their considerable limitations in a dog with occult DCM. The reviewer is struggling to understand the discussion on Vitamin D- Lines 414-416 discuss the differences in analytical methods as possibly being the reason why the greater population of dogs were notably D deficient. If this is the case, then the comparison to the large population is not applicable. The reviewer is just questioning the comments in this section as these comments appear to negate the findings. Line 446 just simply mentions the pea protein concerns- and the author is trying to assuage their audience of its use in dogs, why is there so little information in the discussion. To the reviewer, it appears as an afterthought and not worthy of my time as a reader. 450-458 simply states what the author has already said- unacceptable to be restated. 460-471 is simply just more words to fill the page and can be stated in a simple sentence in the introduction rather than a paragraph in the discussion. Following a brief discussion of findings, the reader is again presented with a paragraph on PBD- the author again needs to keep these thoughts together rather than spread them out through the discussion in a haphazard fashion. Reviewer #2: The authors evaluated the effect of a pea-based protein diet in dogs, detecting its safety through clinical information and various laboratory parameters. The authors themselves highlighted and made it clear that the main limitation of the study is its duration of only one year. In this regard, it is difficult to extrapolate that these results are conclusive when considering longer periods, and as the authors mention, further studies will be necessary for confirmation. Another significant limitation mentioned includes cardiac evaluation, as the markers used may not adequately reflect cardiac function, and the time for the development of nutritional cardiopathy is relatively short. As these limitations have been adequately discussed, I believe the manuscript should be published, as it truly opens perspectives for dietary changes in dogs, providing evidence to support this change. Some minor points are included in the sequence. Introduction Lines 48-52: The authors used two initial references that provide broad information about immunity and nutrition in reference to dogs, but current knowledge does not allow for such extrapolations. Line 78: The authors should bring the meaning of the acronym AAFCO in full. MATERIALS AND METHODS Study design The main concern of this reviewer is whether, in fact, the dogs received only plant-based food, that is, whether the tutors did not provide any other type of food during the study. Reviewer #3: The manuscript is very well and clearly written. I have only two comments: - Would it be possible to analyse urine for taurine? Urinary taurine is considered by many researchers to be the most reliable measure of taurine status and would add to the understanding of whether the dogs are retaining or at risk of becoming depleted in taurine - The Discussion is quite long, largely because the results are being repeated in the text. I recommend that the authors make efforts to reframe the Discussion. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Anne Marie Bakke, Prof. Dr.med.vet. ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-23-18094R1Domestic dogs maintain clinical, nutritional, and hematological health outcomes when fed a commercial plant-based diet for a yearPLOS ONE Dear Dr. Melgarejo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. GIVEN THE SUGGESTION OF REJECTION FROM THE LAST REVIEWER I SOUGHT ADDITIONAL FEEDBACK FROM TWO REVIEWERS. I BELIEVE THE COMMENTS FROM REVIEWER #4 MUST BE ADDRESSED IN A REVISED VERSION BEFORE A FINAL DECISION CAN BE MADE. Please submit your revised manuscript by Dec 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Juan J Loor Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: The authors responded adequately to the questions presented and the limitations of the study were adequately highlighted, so I believe that the manuscript is suitable for publication. Reviewer #4: While I agree that the paper and findings support the use of plant-based diets as the main source of nutrition, there is still the possibility of alternative nutrition being available and uncontrollable, as well as a lack of a control group to compare to. The use of the baseline as each individual control is quite far removed from the end of the study (a year later) with limited ability to understand aging or seasonal effects to the parameters. 1 - 11 years is a big range on top of potential breed confounding factors. STUDY DESIGN: L99-101: Why is there reference to a sample timeframe of every 3 months if it was disregarded for the analysis? If the samples were taken I feel it would be valuable to show the data, even if it is not analyzed in the final dataset. RESULTS: There is no mention of the questionnaire results. Due to their inclusion in the methods, this is a miss. DISCUSSION: This contains references to figures already described in the results (i.e. Fig 1, Fig 2 etc) and feels repetitive. I don't believe there is a need to re-reference the figure references. L389: statement should include lack of analysis of Taurine in urine too. L441-444: mention of questionnaire again but no clarity on any results/findings from this. This section implies that the questionnaire would give clarity or reassurance on the compliance to the study protocol (i.e. no meat-based treats), however the questions do not cover additional feeding explicitly. I am concerned that the questionnaire is inadequate to aid in ensuring compliance. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #4: Yes: Jennifer Carolyn Coltherd ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Domestic dogs maintain clinical, nutritional, and hematological health outcomes when fed a commercial plant-based diet for a year PONE-D-23-18094R2 Dear Dr. Melgarejo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Juan J Loor Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-23-18094R2 PLOS ONE Dear Dr. Melgarejo, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Juan J Loor Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .